Comparing survival between peritoneal dialysis and hemodialysis treatment in ESRD patients with chronic hepatitis c infection

Peritoneal Dialysis International

Volumn 30, Issue 1, 2010, Pages 86-90

  Chou, Che Yi ^a   Wang, I Kuan ^a   Liu, Jiung Hsiun ^a   Lin, Hsin Hung ^a   Wang, Shu Ming ^a   Huang, Chiu Ching ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cardiovascular disease; Hemodialysis; Hepatitis B; Hepatitis c; Mortality

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; SERUM ALBUMIN;

AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC GLOMERULONEPHRITIS; CONTROLLED STUDY; DIABETES MELLITUS; HEART ARRHYTHMIA; HEMATOCRIT; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MORTALITY; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROPENSITY SCORE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME;

EID: 77957666672     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.1177/089686081003000101     Document Type: Article

References (32)

1. Nakayama E, Akiba T, Marumo F, Sato C. Prognosis of antihepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000; 11: 1896-902.
2. Kalantar-Zadeh K, McAllister CJ, Miller LG. Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study. Nephrol Dial Transplant 2005; 20:1662-9.
3. Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998; 32:629-34.
4. Wang SM, Liu JH, Chou CY, Huang CC, Shih CM, Chen W. Mortality in hepatitis C-positive patients treated with peritoneal dialysis. Perit Dial Int 2008; 28:183-7.
5. Lee GS, Roy DK, Fan FY, Thanaletchumi K, Woo KT. Hepatitis C antibodies in patients on peritoneal dialysis: prevalence and risk factors. Perit Dial Int 1996; 16(Suppl 1): S424-8.
6. Puttinger H, Vychytil A. Hepatitis B and C in peritoneal dialysis patients. Semin Nephrol 2002; 22:351-60.
7. Huang CC, Wu MS, Lin DY, Liaw YF. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1992; 12:31-3.
8. Sun CA, Chen HC, Lu SN, Chen CJ, Lu CF, You SL, et al. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol 2001; 65:30-4.
9. Hung KY, Shyu RS, Huang CH, Tsai TJ, Chen WY. Viral hepatitis in continuous ambulatory peritoneal dialysis patients in an endemic area for hepatitis B and C infection: the Taiwan experience. Blood Purif 1997; 15:195-9.
10. Mizuno M, Higuchi T, Yanai M, Kanmatsuse K, Esumi M. Dialysis-membrane-dependent reduction and adsorption of circulating hepatitis C virus during hemodialysis. Nephron 2002; 91:235-42.
11. Chen CB, Chen YC, Tseng YH, Huang CC, Chen W, Shih CM. Chronic hepatitis C infection is associated with higher hemoglobin levels in hemodialysis patients, but hepatitis B infection is not. Dialysis & Transplantation 2008; 37: 12-17.
12. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70:41-55.
13. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335:453-61.
14. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98:946-52.
15. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345:479-86.
16. Ahmed A, Rich MW, Love TE, Lloyd-Jones DM, Aban IB, Colucci WS, et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 2006; 27:178-86.
17. Chen CJ, Wang LY, Yu MW. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol 2000; 15(Suppl):E3-6.
18. Chen DS, Kuo GC, Sung JL, Lai MY, Sheu JC, Chen PJ, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 1990; 162:817-22.
19. Fabrizi F, Messa P, Martin P. Hepatitis B virus infection and the dialysis patient. Semin Dial 2008; 21:440-6.
20. Visnja L, Milan S, Jelena M, Vanja R, Ljubica D. Hepatitis B and hepatitis C virus infection and outcome of hemodialysis and kidney transplant patients. Ren Fail 2008; 30: 81-7.
21. Just PM, de Charro FT, Tschosik EA, Noe LL, Bhattacharyya SK, Riella MC. Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol Dial Transplant 2008; 23:2365-73.
22. Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004; 65:2335-42.
23. Li PK, Chow KM, Wong TY, Leung CB, Szeto CC. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med 2003; 139: 105-12.
24. Winkelmayer WC, Glynn RJ, Mittleman MA, Levin R, Pliskin JS, Avorn J. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol 2002; 13:2353-62.
25. Jaar BG, Coresh J, Plantinga LC, Fink NE, Klag MJ, Levey AS, et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 2005; 143: 174-83.
26. Chu JH, Gange SJ, Anastos K, Minkoff H, Cejtin H, Bacon M, et al. Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy. Am J Epidemiol 2005; 161:881-90.
27. Goksin I, Baltalarli A, Sacar M, Sungurtekin H, Ozcan V, Gurses E, et al. Preservation of pleural integrity in patients undergoing coronary artery bypass grafting: effect on postoperative bleeding and respiratory function. Acta Cardiol 2006; 61:89-94.
28. Reicher B, Poston RS, Mehra MR, Joshi A, Odonkor P, Kon Z, et al. Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes. Am Heart J 2008; 155:661-7.
29. Winkelmayer WC, Kurth T. Propensity scores: help or hype? ERA-EDTA 2004; 19:1671-3.
30. Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med 2008; 27:2037-49.
31. Nelson CB, Port FK, Wolfe RA, Guire KE. Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s. J Am Soc Nephrol 1992; 3:1147-55.
32. Barrera JM. Diagnostic tests for hepatitis C virus infection. Nephrol Dial Transplant 2000; 15(Suppl 8):15-18.